CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Werewolf and Ambros to tie the knot in $150M rare disease deal

Positive
AI Analysis

Summary

Werewolf Therapeutics and Ambros Therapeutics announced a $150M merger deal creating a new company under Ambros' name to advance development of Ambros' non-opioid painkiller for patients with debilitating limb injuries.

Importance:7/10
Sentiment:
0.60
M&Amergerrare diseasepain managementnon-opioid

Read the original article

Published by BioSpace on August 21, 2026 2:27 PM

Read Original